AstraZeneca's Bevespi takes discouraging hit in head-to-head test against GSK
admin 23rd August 2018 Uncategorised 0AstraZeneca’s strategy for taking on GlaxoSmithKline in the respiratory department hasn’t been playing out as planned. Just witness the latest failure: Its COPD med Bevespi fell flat in a head-to-head test against GSK’s Anoro.
More: AstraZeneca's Bevespi takes discouraging hit in head-to-head test against GSK
Source: fierce